MET and colorectal cancer: Among these compounds, 10a was identified as the most potent HGFR/MST1R dual inhibitor (HGFR IC50=0.11 μM and MST1R IC50=0.045 μM) with excellent anti-colorectal cancer activity (COLO 205 IC50=0.11 μM).